News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Chairman's Address to 2011 Annual General Meeting
Chairman's Address to the 2011 Annual General Meeting held on 21 November 2011
Read full media release - pdf
Institutional Component of Entitlement Offer
Pharmaxis Ltd (ASX: PXS) today announced that it has successfully raised approximately $50 million through the institutional component of its 1 for 3 pro-rata accelerated non-renounceable entitlement offer at $1.05 per share (Institutional Entitlement Offer) announced on 16 November 2011.
Key points:
• Strong demand in the Institutional Entitlement Offer from existing and new institutional shareholders
• Underwritten amount increased from $40 million to the full Entitlement Offer size of approximately $80 million
• Eligible retail shareholders to participate in the Retail Entitlement Offer, commencing 24 November 2011
Read full media release - pdf
Pharmaxis announces pro-rata entitlement offer to raise up to approximately A$80 million
Pharmaxis Ltd (Pharmaxis or the Company) (ASX: PXS) today announced a 1 for 3 pro-rata accelerated non-renounceable entitlement offer to eligible shareholders to raise up to approximately $80 million (Entitlement Offer).
The Entitlement Offer is underwritten to $40 million by Merrill Lynch International (Australia) Ltd and Wilson HTM Corporate Finance Ltd.
Read full media release - pdf